Insider · CIK 0001914164
Edward Morrow Atkinson III
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA), ETNB (89bio, Inc.). First filing Feb 12, 2025, latest Feb 28, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRTX: VERTEX PHARMACEUTICALS INC / MA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | VERTEX PHARMACEUTICALS INC / MA | $1.3M 2,650 shares | -12% | +20% from low-8% from high | |
| 33Weak | VERTEX PHARMACEUTICALS INC / MA | $850k 1,767 shares | -7% | +21% from low-7% from high | |
| 32Weak | VERTEX PHARMACEUTICALS INC / MA | $803k 1,747 shares | -7% | +15% from low-12% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -2,482 | $479.61 | $1.2M | 22,002 | Feb 28, 2025 |
| Feb 27, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,650 | $475.34 | $1.3M | 19,352 | Feb 28, 2025 |
| Feb 24, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,656 | $483.28 | $800k | 26,251 | Feb 26, 2025 |
| Feb 25, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,767 | $480.95 | $850k | 24,484 | Feb 26, 2025 |
| Feb 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -1,529 | $463.46 | $709k | 27,907 | Feb 19, 2025 |
| Feb 12, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +6,211 | $0.00 | $0 | 29,436 | Feb 14, 2025 |
| Feb 10, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -876 | $467.98 | $410k | 24,972 | Feb 12, 2025 |
| Feb 11, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,747 | $459.83 | $803k | 23,225 | Feb 12, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +5,132 | $0.00 | $0 | 21,104 | Feb 6, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +4,744 | $0.00 | $0 | 25,848 | Feb 6, 2025 |
| Feb 3, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,400 | $0.00 | $0 | 56,400 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.